Rubio-Pérez, LauraFrago, SusanaCompte, MartaNavarro, RocíoHarwood, Seandean L.Lázaro-Gorines, RodrigoGómez-Rosel, MarinaHangiu, OanaSilva-Pilipich, NoeliaVanrell, LucíaSmerdou, CristianÁlvarez-Vallina, Luis2026-02-042026-02-042024-06Rubio-Pérez, L, Frago, S, Compte, M, Navarro, R, Harwood, S L, Lázaro-Gorines, R, Gómez-Rosel, M, Hangiu, O, Silva-Pilipich, N, Vanrell, L, Smerdou, C & Álvarez-Vallina, L 2024, 'Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity', Antibodies, vol. 13, no. 2, 34. https://doi.org/10.3390/antib130200342073-4468PubMedCentral: PMC11130918https://hdl.handle.net/10641/7817Publisher Copyright: © 2024 by the authors.1447452enginfo:eu-repo/semantics/openAccess4-1BB costimulationcancer immunotherapyepithelial growth factor receptorimmune checkpoint blockadetrispecific antibodyImmunology and AllergyImmunologyDrug DiscoverySDG 3 - Good Health and Well-beingJournal ArticleYesyes/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article10.3390/antib13020034https://www.scopus.com/pages/publications/85197202126https://www.scopus.com/pages/publications/85197202126#tab=citedBy